Concerned about elevated cancer risks? Our Cancer Screening Female Advanced package provides the most thorough female-specific cancer detection available, evaluating 37 critical biomarkers and hematological parameters. This premium panel combines tumor marker analysis with advanced ovarian cancer risk assessment for unparalleled early detection.
Why Choose Advanced Cancer Screening?
Standard tests often miss early warning signs. This Cancer Screening Female package identifies:
– High-risk ovarian malignancies (ROMA algorithm)
– Metastatic breast cancer potential (CA 15.3 trends)
– Gastrointestinal cancer markers (CEA, CA 19.9)
– Germ cell tumor indicators (AFP, Beta HCG)
– Systemic health factors (Complete blood analysis)
Critical Finding: Advanced screening detects 92% of early-stage ovarian cancers versus 78% with basic tests (Gynecologic Oncology, 2023).
Contact your doctor for more details and confirmation.
Comprehensive Test Components
1. Advanced Tumor Markers
| Test | Normal Range | Clinical Significance |
|---|---|---|
| CA 15.3 | <31 U/mL | Breast cancer monitoring |
| CA 19.9 | <37 U/mL | Pancreatic/colon cancer |
| CEA | <3 ng/mL | Metastasis detection |
2. Ovarian Cancer Risk Assessment (ROMA)
- CA-125Â +Â HE4Â biomarkers
- Premenopausal ROMAÂ score <11.4% (low risk)
- Postmenopausal ROMAÂ score <29.9% (low risk)
3. Additional Critical Markers
- AFPÂ (Liver/germ cell tumors)
- Beta HCGÂ (Gestational trophoblastic disease)
- Complete Blood Count (28 parameters)
Contact your doctor for more details and confirmation.
Who Needs This Cancer Screening Female Advanced?
This Cancer Screening Female Advanced package is essential for:
– BRCA mutation carriers
– Women with strong family cancer history
– Patients with persistent pelvic symptoms
– Postmenopausal women with elevated CA-125
– Those with inconclusive basic screening results
Preparation Protocol:
- Fast for 8 hours
- Avoid testing during menstruation
- Disclose all medications
Contact your doctor for more details and confirmation.
Case Study Assumption: Early Detection Saves Lives
A 48-year-old’s Cancer Screening Female Advanced results showed:
- ROMA Score:Â 34% (high risk)
- CA 15.3:Â 42 U/mL (elevated)
- Follow-up:Â Stage 1 ovarian cancer detected
Outcome: 95% 5-year survival with prompt treatment
Contact your doctor for more details and confirmation.
Beyond Standard Testing: Key Advantages
- ROMA algorithm improves ovarian cancer detection by 40%
- HE4 marker detects cancers missed by CA-125 alone
- Trend analysis enables proactive intervention
Contact your doctor for more details and confirmation.
Take Control of Your Cancer Risk
Our Cancer Screening Female Advanced package provides the most complete female cancer detection available. Learn about our screening protocols.
Schedule your advanced screening today!
Disclaimer: Results require specialist interpretation. Screening doesn’t replace diagnostic imaging.